ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MNKD MannKind Corporation

4.3216
-0.0584 (-1.33%)
After Hours
Last Updated: 22:50:04
Delayed by 15 minutes
Share Name Share Symbol Market Type
MannKind Corporation NASDAQ:MNKD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0584 -1.33% 4.3216 4.35 4.48 4.49 4.34 4.45 1,836,286 22:50:04

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against MannKind Corp. & Encourages Inves...

10/02/2016 8:44pm

Business Wire


MannKind (NASDAQ:MNKD)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more MannKind Charts.

Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against MannKind Corp. (“MannKind” or the “Company”) (Nasdaq: MNKD). Investors who purchased or otherwise acquired shares between August 10, 2015 and January 5, 2016, (the “Class Period”), are encouraged to contact the firm in advance of the March 15, 2016, lead plaintiff motion deadline.

If you are a shareholder who suffered a loss during the Class Period, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 708, Marina Del Rey, CA 90292, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the complaint, the Company failed to disclose that, contrary to the Company’s assurances, the mandated pulmonary testing or spirometry was still a significant issue impeding sales of Afrezza.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Goldberg Law PC, Los AngelesMichael Goldberg, Esq., 800-977-7401Brian Schall, Esq., 800-977-7401info@goldberglawpc.com

1 Year MannKind Chart

1 Year MannKind Chart

1 Month MannKind Chart

1 Month MannKind Chart

Your Recent History

Delayed Upgrade Clock